CONSOLIDATED BALANCE SHEETS - USD ($)		Dec. 31, 2021		Dec. 31, 2020
Current assets
Cash and cash equivalents		$ 299,968,000		$ 92,348,000
Short-term investments		293,851,000		4,098,000
Investment securities, available-for sale (Amortized cost: 2021: $21,142; 2020: $0)		21,131,000		0
Investment securities, held-to-maturity (Fair value: 2021: $307; 2020: $266)		305,000		265,000
Accrued retrospective premiums		34,923,000		34,829,000
Other receivables		14,282,000		11,368,000
Healthcare receivable		48,042,000		38,745,000
Surety bonds and deposits		12,613,000		0
Prepaid expenses		9,409,000		7,830,000
Other assets, current		18,022,000		299,000
Total current assets		752,546,000		189,782,000
Investment securities, available-for sale (Amortized cost: 2021: $177,527; 2020: $53,953)		175,604,000		53,963,000
Investment securities, held-to-maturity (Fair value: 2021: $364; 2020: $471)		335,000		429,000
Property and equipment, net		2,287,000		2,078,000
Operating lease right-of-use assets		5,367,000		7,882,000
Goodwill and other intangible assets		4,233,000		4,233,000
Other assets, non-current		10,432,000		8,885,000
Total assets		950,804,000		267,252,000
Current liabilities
Unpaid claims		138,604,000		102,429,000
Due to related parties, net		2,320,000		1,547,000
Direct Contracting performance year obligation		36,891,000		0
Direct Contracting payable		37,773,000		0
Accounts payable and accrued expenses		28,129,000		30,671,000
Accrued salaries and benefits		15,147,000		3,978,000
Operating lease liabilities		3,059,000		4,795,000
Current portion of notes and securities payable		0		20,803,000
Premium deficiency reserve		110,628,000		0
Other liabilities, current		73,000		5,000
Total current liabilities		372,624,000		164,228,000
Notes and securities payable, net of discounts, and deferred issuance costs		19,938,000		106,413,000
Derivative liabilities		0		44,810,000
Warrants payable		0		97,782,000
Long-term operating lease liabilities		4,830,000		6,349,000
Other liabilities, non-current		14,095,000		13,116,000
Total liabilities		411,487,000		432,698,000
Commitments and Contingencies (Note 21 )
Convertible Preferred stock (Series Seed A, A-1, B, C, and D), $0.0001 par value; 0 and 155,387,025 shares authorized as of December 31, 2021, and 2020, respectively; 0 and 139,444,346 shares issued and outstanding as of December 31, 2021, and 2020, respectively; aggregate liquidation preference of $0 and $470,256 as of December 31, 2021, and 2020, respectively (1)	[1]	0		447,747,000
Stockholders' equity (deficit)
Additional paid-in capital		2,154,187,000		411,867,000
Accumulated other comprehensive (loss) income		(1,934,000)		10,000
Accumulated deficit		(1,616,738,000)		(1,028,982,000)
Less: Treasury stock, at cost; 14,730 and 0 shares held as of December 31, 2021, and 2020, respectively		(147,000)		0
Total stockholders’ equity (deficit)		535,414,000		(617,096,000)
Noncontrolling interest		3,903,000		3,903,000
Total stockholders' equity (deficit)		539,317,000		(613,193,000)
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit)		950,804,000		267,252,000
Common Class A
Stockholders' equity (deficit)
Common stock, value		34,000		0
Common Class B
Stockholders' equity (deficit)
Common stock, value		$ 12,000	[1]	$ 9,000

[1] Prior period results have been adjusted to reflect the exchange of Legacy Clover's common stock for Clover Class B Common Stock at an exchange ratio of approximately 2.0681 in January 2021 as a result of the Business Combination. See Note 3 (Business Combination) for additional information.